Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis

• Shadi Mamaghani,

  Affiliations Division of Applied Molecular Oncology, University Health Network, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• Craig D. Simpson,

  Affiliation Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• Pinjiang M. Cao,

  Affiliations Division of Applied Molecular Oncology, University Health Network, Toronto, Ontario, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• May Cheung,

  Affiliations Division of Applied Molecular Oncology, University Health Network, Toronto, Ontario, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• Sue Chow,

  Affiliations Division of Applied Molecular Oncology, University Health Network, Toronto, Ontario, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• Bizhan Bandarchi,

  Affiliation Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• Aaron D. Schimmer,

  Affiliations Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada, Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯
• David W. Hedley

  * E-mail: david.hedley@uhn.on.ca

  Affiliations Division of Applied Molecular Oncology, University Health Network, Toronto, Ontario, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada, Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada

  ⨯